Literature DB >> 21604317

Gastrostomy tube placement and use in patients with head and neck cancer.

Julie L Locher1, James A Bonner, William R Carroll, Jimmy J Caudell, Meredith L Kilgore, Christine S Ritchie, David L Roth, Gabriel S Tajeu, Ya Yuan, Jeroan J Allison.   

Abstract

BACKGROUND: Enteral nutritional support is used in care for patients with head and neck cancer. This study describes the frequency and timing of gastrostomy tube placement and corresponding Medicare nutritional support claims in patients with head and neck cancer.
METHODS: Surveillance, Epidemiology, and End Results (SEER)-Medicare data for patients with head and neck cancer diagnosed from 2000 to 2005 were used in this descriptive study (N = 16,458).
RESULTS: In all, 35.1% of patients undergoing treatment had gastrostomy tubes placed; 16.9% had tubes placed before treatment, whereas 83.1% had them placed after treatment. Of those having tubes placed prior to treatment 23.7% had Medicare claims for nutritional support before treatment and 40.9% had claims after treatment began. A total of 35.4% of patients who had tubes placed before treatment and 35.5% who had tubes placed after treatment had no claims for nutritional support.
CONCLUSIONS: Future work is warranted to identify predictors and outcomes associated with provision and timing of enteral nutrition support for patients with head and neck cancer.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21604317     DOI: 10.1002/hed.21753

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

1.  Treatment-related toxicities in older adults with head and neck cancer: A population-based analysis.

Authors:  Caitriona B O'Neill; Shrujal S Baxi; Coral L Atoria; James P O'Neill; Martin C Henman; Eric J Sherman; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Cancer       Date:  2015-02-27       Impact factor: 6.860

2.  Increased likelihood of long-term gastrostomy tube dependence in head and neck cancer survivors without partners.

Authors:  J Scott Magnuson; Jennifer Durst; Eben L Rosenthal; William R Carroll; Christine S Ritchie; Meredith L Kilgore; Julie L Locher
Journal:  Head Neck       Date:  2012-04-14       Impact factor: 3.147

3.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

4.  Patterns of prophylactic gastrostomy tube placement in head and neck cancer patients: a consideration of the significance of social support and practice variation.

Authors:  Julie L Locher; James A Bonner; William R Carroll; Jimmy J Caudell; Jeroan J Allison; Meredith L Kilgore; Christine S Ritchie; Gabriel S Tajeu; Ya Yuan; David L Roth
Journal:  Laryngoscope       Date:  2013-02-07       Impact factor: 3.325

5.  Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.

Authors:  Ronald J Maggiore; Emily K Curran; Mary Ellyn Witt; Daniel J Haraf; Everett E Vokes; Ezra E W Cohen
Journal:  J Geriatr Oncol       Date:  2013-06-10       Impact factor: 3.599

6.  Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer.

Authors:  Crispin O Musumba; Julia Hsu; Golo Ahlenstiel; Nicholas J Tutticci; Kavinderjit S Nanda; David van der Poorten; Eric Y Lee; Vu Kwan
Journal:  Gastroenterol Res Pract       Date:  2015-04-21       Impact factor: 2.260

7.  Oral cancer malnutrition impacts weight and quality of life.

Authors:  Nils-Claudius Gellrich; Jörg Handschel; Henrik Holtmann; Gertrud Krüskemper
Journal:  Nutrients       Date:  2015-03-27       Impact factor: 5.717

8.  Development of Late Toxicities in Patients with Oral Tongue Cancer Treated with Surgical Resection and Adjuvant Radiation Therapy.

Authors:  Mutlay Sayan; Richard J Cassidy; Jeffrey M Switchenko; Oluwatosin A Kayode; Nabil F Saba; Conor E Steuer; Dong M Shin; J Trad Wadsworth; Mark El-Deiry; Mihir Patel; Jonathan J Beitler; Kristin A Higgins
Journal:  Front Oncol       Date:  2017-01-11       Impact factor: 6.244

9.  Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI).

Authors:  Frank E Mott; Ruth Sacks; Faye Johnson; Katherine A Hutcheson; Natalie Gallagher; Susan Varghese; Jhankruti Zaveri
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-11-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.